Biniszkiewicz Detlev 4
4 · iTeos Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Biniszkiewicz Detlev
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+17,538→ 17,538 totalExercise: $18.78Exp: 2032-06-09→ Common Stock (17,538 underlying)
Footnotes (1)
- [F1]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 9, 2023 or (b) the next annual meeting of the Issuer's stockholders.